Costs · people with major upper gastrointestinal, liver and pancreatic surgery
1 finding from 1 review
Intervention not reported
Estimated total blood loss (mL) · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
The intervention showed no clear difference in estimated total blood loss (mL) (low certainty).
1 finding from 1 review
Intervention not reported
Number of transfused units of red blood cell (RBC) · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
The intervention showed no clear difference in number of transfused units of red blood cell (RBC) (low certainty).
1 finding from 1 review
Intervention not reported
Number of transfused units of plasma · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
The intervention showed no clear difference in number of transfused units of plasma (low certainty).
1 finding from 1 review
Intervention not reported
Rate of RBC transfusion (total number of participants who required at least one unit of red blood cell transfusion) Time: perioperative and postoperative periods · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
The intervention showed no clear difference in rate of RBC transfusion (total number of participants who required… (low certainty).
1 finding from 1 review
Intervention not reported
Rate of plasma transfusion (total number of participants who required at least one unit of plasma transfusion) Time: perioperative and postoperative periods · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
The intervention showed no clear difference in rate of plasma transfusion (total number of participants who… (low certainty).
1 finding from 1 review
Intervention not reported
Reoperation (Number of participants with at least one reoperation) Time: perioperative periods · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
It is very uncertain whether the intervention changes reoperation (Number of participants with at least one reoperation)… (very low certainty).
1 finding from 1 review
Intervention not reported
Readmission (Number of participants with at least one readmission) Time: perioperative periods) · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
It is very uncertain whether the intervention changes readmission (Number of participants with at least one readmission)… (very low certainty).
1 finding from 1 review
Intervention not reported
Venous thromboembolic events (number of participants with at least one venous thromboembolic events) Time: 5‐week · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
It is very uncertain whether the intervention changes venous thromboembolic events (number of participants with at least… (very low certainty).
1 finding from 1 review
Intervention not reported
Arterial thromboembolic events (number of participants with at least one venous thromboembolic events) Time: 5‐week · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
It is very uncertain whether the intervention changes arterial thromboembolic events (number of participants with at least… (very low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality · individuals with atrial fibrillation who are undergoing cardiac surgery
The intervention showed no clear difference in all‐cause mortality (low certainty).
1 finding from 1 review
Intervention not reported
Freedom from AF/AFL/AT off antiarrhythmic medications > 3 months · individuals with atrial fibrillation who are undergoing cardiac surgery
The intervention probably leads to higher freedom from AF/AFL/AT off antiarrhythmic medications > 3 months (moderate certainty).
1 finding from 1 review
Intervention not reported
Investigator‐defined adverse events · individuals with atrial fibrillation who are undergoing cardiac surgery
It is very uncertain whether the intervention changes investigator‐defined adverse events (very low certainty).
1 finding from 1 review
Intervention not reported
Pacemaker implantation4 · individuals with atrial fibrillation who are undergoing cardiac surgery
The intervention probably leads to higher pacemaker implantation4 (moderate certainty).
1 finding from 1 review
Intervention not reported
30‐day mortality4 · individuals with atrial fibrillation who are undergoing cardiac surgery
The intervention showed no clear difference in 30‐day mortality4 (low certainty).
1 finding from 1 review
Pain score none1. Scale from: 0 to 4. · patients undergoing cataract surgery
1 finding from 1 review
Globe akinesia extraocular muscle motility · patients undergoing cataract surgery
Peribulbar showed no clear difference in globe akinesia extraocular muscle motility compared with retrobulbar (low certainty).
1 finding from 1 review
Need for additional injection Number of additional injections · patients undergoing cataract surgery
Peribulbar showed no clear difference in need for additional injection Number of additional injections compared with retrobulbar (low certainty).
1 finding from 1 review
Local complications ‐ Retrobular haemorrhage · patients undergoing cataract surgery
Peribulbar showed no clear difference in local complications ‐ Retrobular haemorrhage compared with retrobulbar (moderate certainty).
1 finding from 1 review
Local complications ‐ Conjunctival chemosis presence of conjunctival chemosis · patients undergoing cataract surgery
Peribulbar probably leads to higher local complications ‐ Conjunctival chemosis presence of conjunctival… compared with retrobulbar (moderate certainty).
1 finding from 1 review